3D-QSAR and molecular docking studies of hydroxamic acids as peptide deformylase inhibitors

Medicinal Chemistry Research

Volumn 21, Issue 8, 2012, Pages 1597-1610

  Gao, Jian ^a   Cheng, Yuanhua ^b   Cui, Wei ^a   Chen, Quan ^a   Zhang, Fushi ^b   Du, Yuguo ^a   Ji, Mingjuan ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b Tsinghua University   (China)

Author keywords

3D QSAR; CoMFA; CoMSIA; Docking; PDF

Indexed keywords

HYDROXAMIC ACID; PEPTIDE DEFORMYLASE; PEPTIDE DEFORMYLASE INHIBITOR;

ARTICLE; BINDING AFFINITY; CHEMICAL INTERACTION; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; DRUG PROTEIN BINDING; ENZYME INHIBITION; HYDROGEN BOND; HYDROPHOBICITY; IC 50; MOLECULAR DOCKING; PREDICTIVE VALUE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATIC ELECTRICITY;

EID: 84866070794     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9672-7     Document Type: Article

References (40)

1. Adams JM (1968) On the release of the formyl group from nascent protein. J Mol Biol 33:571-574
2. Adams JM, Capecchi MR (1966) N-formylmethionyl-sRNA as the initiator of protein synthesis. Proc Natl Acad Sci USA 55: 147-155
3. Apfel CM, Locher H, Evers S, Takacs B, Hubschwerlen C, Pirson W, Page MGP, Keck W (2001) Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob Agents Chemother 45:1058-1064
4. Bush BL, Nachbar RB (1993) Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput Aided Mol Des 7:587-619
5. Calí P, Nærum L, Mukhija S, Hjelmencrantz A (2004) Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents. Bioorg Med Chem Lett 14: 5997-6000
6. Chen DZ, Patel DV, Hackbarth CJ, Wang W, Dreyer G, Young DC, Margolis PS, Wu C, Ni ZJ, Trias J, White RJ, Yuan Z (2000) Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry 39:1256-1262
7. Chen D, Hackbarth C, Ni ZJ, Wu C, Wang W, Jain R, He Y, Bracken K, Weidmann B, Patel DV, Trias J, White RJ, Yuan Z (2004) Peptide deformylase inhibitors as antibacterial agents: Identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach. Antimicrob Agents Chemother 48:250-261
8. Clark M, Richard D, Cramer I, Opdenbosch NV (1989) Validation of the general purpose Tripos 5.2 force field. J Comput Chem 10:982-1012
9. Clements JM, Beckett RP, Brown A, Catlin G, Lobell M, Palan S, Thomas W, Whittaker M, Wood S, Salama S, Baker PJ, Rodgers HF, Barynin V, Rice DW, Hunter MG (2001) Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob Agents Chemother 45:563-570
10. Cramer RD III, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959-5967
11. DeLano WL (2002) The PyMOL molecular graphics system. http://www.pymol.org
12. Exner T, Keil M, Moeckel G, Brickmann J (1998) Identifification of substrate channels and protein cavities. J Mol Model 4:340-343
13. Falconer SB, Brown ED (2009) New screens and targets in antibacterial drug discovery. Curr Opin Microbiol 12:497-504
14. Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 36:3219-3228
15. Geladi P (1988) Notes on the history and nature of partial least squares (PLS) modelling. J Chemom 2:231-246
16. Groche D, Becker A, Schlichting I, Kabsch W, Schultz S et al (1998) Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site. Biochem Biophys Res Commun 246: 342-346
17. Guay DRP (2007) Drug forecast-the peptide deformylase inhibitors as antibacterial agents. Ther Clin Risk Manag 3:513-525
18. Hackbarth CJ, Chen DZ, Lewis JG, Clark K, Mangold JB, Cramer JA, Margolis PS, Wang W, Koehn J, Wu C, Lopez S, Withers G III, Gu H, Dunn E, Kulathila R, Pan SH, Porter WL, Jacobs J, Trias J, Patel DV, Weidmann B, White RJ, Yuan Z (2002) N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity. Antimicrob Agents Chemother 46:2752-2764
19. Hou TJ, Xu XJ (2001) Three-dimensional quantitative structureactivity relationship analyses of a series of cinnamamides. Chemom Intell Lab Syst 56:123-132
20. Hou TJ, Li ZM, Li Z, Liu J, Xu XJ (2000) Three-dimensional quantitative structure-activity relationship analysis of the new potent sulfonylureas using comparative molecular similarity indices analysis. J Chem Inf Comput Sci 40:1002-1009
21. Hou TJ, Zhu LL, Chen LR, Xu XJ (2002) Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. J Chem Inf Comput Sci 43:273-287
22. Jain R, Sundram A, Lopez S, Neckermann G, Wu C, Hackbarth C, Chen D, Wang W, Ryder NS, Weidmann B, Patel D, Trias J, White R, Yuan Z (2003) α-Substituted hydroxamic acids as novel bacterial deformylase inhibitor-based antibacterial agents. Bioorg Med Chem Lett 13:4223-4228
23. Kadam RU, Chavan A, Roy N (2007) Pharmacophoric features of Pseudomonas aeruginosa deacetylase LpxC inhibitors: an electronic and structural analysis. Bioorg Med Chem Lett 17:861-868
24. Klebe G, Abraham U (1999) Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries. J Comput Aided Mol Des 13:1-10
25. Klebe G, Abraham U, Mietzner T (1994) Molecular Similarity Indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130-4146
26. Lee J, Doddareddy M, Cho Y, Choo H, Koh H, Kang JH, No K, Pae A (2007) Comparative QSAR studies on peptide deformylase inhibitors. J Mol Model 13:543-558
27. Leeds JA, Dean CR (2006) Peptide deformylase as an antibacterial target: a critical assessment. Curr Opin Pharmacol 6:445-452
28. Livingston DM, Leder P (1969) Deformylation and protein biosynthesis. Biochemistry 8:435-443
29. Lucchini G, Bianchetti R (1980) Initiation of protein synthesis in isolated mitochondria and chloroplasts. Biochim Biophys Acta 608:54-61
30. Molteni V, He X, Nabakka J, Yang K, Kreusch A, Gordon P, Bursulaya B, Warner I, Shin T, Biorac T, Ryder NS, Goldberg R, Doughty J, He Y (2004) Identification of novel potent bicyclic peptide deformylase inhibitors. Bioorg Med Chem Lett 14: 1477-1481
31. Murray JS, Zilles BA, Jayasuriya K, Politzer P (1986) Comparative analysis of the electrostatic potentials of dibenzofuran and some dibenzo-p-dioxins. J Am Chem Soc 108:915-918
32. Rajagopalan PTR, Yu XC, Pei D (1997) Peptide deformylase: a new type of mononuclear iron protein. J Am Chem Soc 119:12418-12419
33. Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261:470-489
34. Sippl W (2000) Receptor-based 3D QSAR analysis of estrogen receptor ligands - merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods. J Comput Aided Mol Des 14:559-572
35. Wang Q, Zhang D, Wang J, Cai Z, Xu W (2006) Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets. Biophys Chem 122:43-49
36. Wold S, Ruhe A, Wold H, Dunn WJIii (1984) The collinearity problem in linear regression. The partial least squares (PLS) approach to generalized inverses. SIAM J Sci Stat Comput 5:735-743
37. Yuan Z, Trias J, White RJ (2001) Deformylase as a novel antibacterial target. Drug Discov Today 6:954-961
38. Zhang D, Wang Z, Xu W, Sun F, Tang L, Wang J (2009) Design, synthesis and antibacterial activity of novel actinonin derivatives containing benzimidazole heterocycles. Eur J Med Chem 44:2202-2210
39. Zhou Z, Song X, Gong W (2005) Novel conformational states of peptide deformylase from pathogenic bacterium Leptospira interrogans. J Biol Chem 280:42391-42396
40. Zhu LL, Hou TJ, Chen LR, Xu XJ (2001) 3D QSAR analyses of novel tyrosine kinase inhibitors based on pharmacophore alignment. J Chem Inf Comput Sci 41:1032-1040